| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4856257
Max Phase: Preclinical
Molecular Formula: C20H29BrN4O
Molecular Weight: 421.38
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCCC(c1nc2cccc(Br)c2c(=O)n1CC)N1C[C@@H](C)N[C@@H](C)C1
Standard InChI: InChI=1S/C20H29BrN4O/c1-5-8-17(24-11-13(3)22-14(4)12-24)19-23-16-10-7-9-15(21)18(16)20(26)25(19)6-2/h7,9-10,13-14,17,22H,5-6,8,11-12H2,1-4H3/t13-,14+,17?
Standard InChI Key: MHQZDIZEHXXDPX-VMZNBEPHSA-N
Associated Targets(Human)
Voltage-gated calcium channel alpha2/delta subunit 1 266 Activities
Cytochrome P450 3A4 53859 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 421.38 | Molecular Weight (Monoisotopic): 420.1525 | AlogP: 3.70 | #Rotatable Bonds: 5 |
| Polar Surface Area: 50.16 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.39 | CX LogP: 3.85 | CX LogD: 1.88 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.80 | Np Likeness Score: -0.71 |
References
| 1. Fernández A, Díaz JL, García M, Rodríguez-Escrich S, Lorente A, Enrech R, Dordal A, Portillo-Salido E, Porras M, Fernández B, Reinoso RF, Vela JM, Almansa C.. (2021) Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels., 12 (11.0): [PMID:34795870] [10.1021/acsmedchemlett.1c00416] |
Source
Source(1):